The effect of venlafaxine on blood pressure and ECG in rats fed with high-fat-fructose diet.

ECG antidepressants blood pressure high-fat-fructose diet metabolic syndrome venlafaxine

Journal

Interdisciplinary toxicology
ISSN: 1337-6853
Titre abrégé: Interdiscip Toxicol
Pays: Slovakia
ID NLM: 101528175

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 14 08 2019
accepted: 20 12 2019
entrez: 29 5 2020
pubmed: 29 5 2020
medline: 29 5 2020
Statut: ppublish

Résumé

Metabolic syndrome represents one of the major health, social and economic issues nowadays, and affects more than 25% people worldwide. Being a multifactorial health problem, metabolic syndrome clusters various features, such as obesity, dyslipidemia, hyperglycemia and hypertension. Each of these disturbances represents a risk factor for developing cardiovascular disease. Moreover, patients with metabolic syndrome are more likely to suffer from depression, thus treatment with antidepressants (

Identifiants

pubmed: 32461723
doi: 10.2478/intox-2019-0024
pii: ITX-12-192
pmc: PMC7247368
doi:

Types de publication

Journal Article

Langues

eng

Pagination

192-199

Informations de copyright

Copyright © 2019 SETOX & Institute of Experimental Pharmacology and Toxicology, SASc.

Références

CNS Drugs. 2010 Sep;24(9):741-53
pubmed: 20806987
Int J Cardiol. 2006 Apr 28;109(1):116-7
pubmed: 16574528
Arch Gen Psychiatry. 2000 May;57(5):503-9
pubmed: 10807491
PLoS One. 2018 Nov 5;13(11):e0206933
pubmed: 30395598
Exp Physiol. 2008 Mar;93(3):362-9
pubmed: 18156165
Am J Med. 2003 Dec 1;115(8):676-7
pubmed: 14656626
Life Sci. 2008 May 23;82(21-22):1131-6
pubmed: 18445498
Physiol Res. 2016 Dec 21;65(Suppl 4):S515-S518
pubmed: 28006934
Clin Sci (Lond). 2018 Feb 28;132(4):461-474
pubmed: 29436481
Cardiovasc Res. 2011 Oct 1;92(1):10-8
pubmed: 21803867
Biochim Biophys Acta Mol Basis Dis. 2017 Jun;1863(6):1568-1574
pubmed: 28254494
Eur J Cardiol. 1980 Feb;11(2):81-90
pubmed: 7363927
Biomed Res Int. 2017;2017:2494067
pubmed: 28497040
Int J Obes (Lond). 2010 Mar;34(3):407-19
pubmed: 19997072
Lancet. 2011 Feb 12;377(9765):557-67
pubmed: 21295846
Int J Cardiol. 2016 Jan 15;203:792-7
pubmed: 26595786
Diabetes Care. 2012 May;35(5):1171-80
pubmed: 22517938
JAMA. 2007 Nov 7;298(17):2028-37
pubmed: 17986696
Circulation. 2008 Mar 11;117(10):1255-60
pubmed: 18285562
Clin Cardiol. 2009 Dec;32(12):E93-9
pubmed: 20014212
Exp Clin Endocrinol Diabetes. 2018 Apr;126(4):205-212
pubmed: 29117620
Hum Psychopharmacol. 2007 Apr;22(3):129-33
pubmed: 17397100
Gen Hosp Psychiatry. 2017 Mar - Apr;45:62-69
pubmed: 28274341
Jpn Heart J. 1990 Jan;31(1):25-33
pubmed: 2335846
Am J Hypertens. 2014 May;27(5):734-41
pubmed: 24084586
Psychol Med. 2014 Jul;44(10):2017-28
pubmed: 24262678
J Pharmacol Exp Ther. 1999 Oct;291(1):280-4
pubmed: 10490914
Atherosclerosis. 2005 Mar;179(1):43-9
pubmed: 15721008
Cell Biochem Funct. 2014 Mar;32(2):133-41
pubmed: 23657904
Lab Anim (NY). 2017 May 22;46(6):251-253
pubmed: 28530692
Int J Exp Pathol. 2017 Oct;98(5):296-306
pubmed: 29210119
Case Rep Psychiatry. 2014;2014:659715
pubmed: 25328745
Int J Cardiol. 2006 Oct 26;113(1):E9-10
pubmed: 16989912
Interdiscip Toxicol. 2017 Nov;10(3):86-92
pubmed: 30174531
Med Princ Pract. 2015;24(2):147-52
pubmed: 25592764
Minerva Gastroenterol Dietol. 1999 Sep;45(3):193-7
pubmed: 16498330
J Mol Cell Cardiol. 2015 Feb;79:275-83
pubmed: 25497302
Asian J Psychiatr. 2015 Aug;16:63-4
pubmed: 26187237
J Hypertens. 2005 Jun;23(6):1241-9
pubmed: 15894901
Arch Gen Psychiatry. 2006 Jul;63(7):824-30
pubmed: 16818872

Auteurs

Michaela Sasváriová (M)

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University in Bratislava, Slovakia.

Dominika Micháliková (D)

Institute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine of the Slovak Academy of Sciences, Bratislava, Slovakia.

Barbara Tyukos Kaprinay (BT)

Institute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine of the Slovak Academy of Sciences, Bratislava, Slovakia.

Lazaros Salvaras (L)

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University in Bratislava, Slovakia.

Slavomila Hričáková (S)

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University in Bratislava, Slovakia.

Vladimír Knezl (V)

Institute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine of the Slovak Academy of Sciences, Bratislava, Slovakia.

Zdenka Gáspárová (Z)

Institute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine of the Slovak Academy of Sciences, Bratislava, Slovakia.

Tatiana Stankovičová (T)

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University in Bratislava, Slovakia.

Classifications MeSH